文献速递精神分裂症与精神病性障碍

mTOR激酶活性破坏精神分裂症脑内磷酸化信号网络

mTOR kinase activity disrupts a phosphorylation signaling network in schizophrenia brain.
PubMed 文献 · Mol Psychiatry · 2021-05-14

该研究在精神分裂症死者背外侧前额叶皮层及大鼠模型中,检测mTOR复合物下游效应蛋白表达与激酶活性谱,发现S6RP磷酸化降低、PKCα磷酸化升高,且患者激酶网络对雷帕霉素更敏感,AMPK参与其中。

要点

  • 精神分裂症DLPFC中mTORC1下游S6RP磷酸化降低,mTORC2下游PKCα磷酸化升高。
  • 长期氟哌啶醇处理大鼠额叶皮层S6RP磷酸化升高,提示抗精神病药新机制。
  • 精神分裂症死者激酶网络对雷帕霉素全局更敏感,AMPK参与差异激酶活性。

核心结论

  • 精神分裂症脑内mTOR激酶活性紊乱导致下游磷酸化信号网络异常,mTOR可能作为激酶活性主调控因子。

研究设计与样本

  • 研究采用精神分裂症死者背外侧前额叶皮层组织、长期氟哌啶醇处理大鼠及死后组织雷帕霉素抑制实验,结合激酶肽阵列分析。

主要发现

  • 精神分裂症DLPFC中mTORC1下游S6RP磷酸化降低,而mTORC2下游PKCα磷酸化升高。
  • 长期氟哌啶醇处理大鼠额叶皮层S6RP磷酸化升高。
  • 激酶肽阵列显示精神分裂症与对照者男女双方均存在激酶信号网络关键差异。
  • 精神分裂症死者激酶网络对雷帕霉素抑制全局更敏感,AMPK参与该差异激酶活性。

临床怎么用

  • 提示mTOR信号通路可能作为精神分裂症治疗干预的潜在靶点。
  • 氟哌啶醇升高S6RP磷酸化提示抗精神病药可能通过mTORC1下游发挥作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The AKT-mTOR signaling transduction pathway plays an important role in neurodevelopment and synaptic plasticity. mTOR is a serine/threonine kinase that modulates signals from multiple neurotransmitters and phosphorylates specific proteins to regulate protein synthesis and cytoskeletal organization. There is substantial evidence demonstrating abnormalities in AKT expression and activity in different schizophrenia (SZ) models. However, direct evidence for dysregulated mTOR kinase activity and its consequences on downstream effector proteins in SZ pathophysiology is lacking. Recently, we reported reduced phosphorylation of mTOR at an activating site and abnormal mTOR complex formation in the SZ dorsolateral prefrontal cortex (DLPFC). Here, we expand on our hypothesis of disrupted mTOR signaling in the SZ brain and studied the expression and activity of downstream effector proteins of mTOR complexes and the kinase activity profiles of SZ subjects. We found that S6RP phosphorylation, downstream of mTOR complex I, is reduced, whereas PKCα phosphorylation, downstream of mTOR complex II, is increased in SZ DLPFC. In rats chronically treated with haloperidol, we showed that S6RP phosphorylation is increased in the rat frontal cortex, suggesting a potential novel mechanism of action for antipsychotics. We also demonstrated key differences in kinase signaling networks between SZ and comparison subjects for both males and females using kinome peptide arrays. We further investigated the role of mTOR kinase activity by inhibiting it with rapamycin in postmortem tissue and compared the impact of mTOR inhibition in SZ and comparison subjects using kinome arrays. We found that SZ subjects are globally more sensitive to rapamycin treatment and AMP-activated protein kinase (AMPK) contributes to this differential kinase activity. Together, our findings provide new insights into the role of mTOR as a master regulator of kinase activity in SZ and suggest potential targets for therapeutic intervention.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Chadha R, Alganem K, Mccullumsmith RE, et al. mTOR kinase activity disrupts a phosphorylation signaling network in schizophrenia brain. Mol Psychiatry. 2021. PMID: 33990769. doi:10.1038/s41380-021-01135-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。